Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA-NP+M1 in Influenza H3N2 Challenge
NCT03883113Phase 2Completed
- Sponsor
- Barinthus Biotherapeutics
- Start
- Jun 2019
- Primary completion
- Dec 2019
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of VTP-100 in influenza, sponsored by Barinthus Biotherapeutics. Started Jun 2019; status: completed.
02
Drugs
VTP-100
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03883113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03883113.